Target Zero is a new initiative that aims to improve the time to access for patients in Canada for new drugs that are proven to be effective.
The ...
Latest News
CADTH has developed a comprehensive and accessible tool to support the validation of economic models used in health technology assessments (HTAs).
Econ ...
We are testing a new approach that brings the societal perspective to our economic evaluations of certain new drugs.
When a drug sponsor submits a drug ...
Current Consultation Status: Open Consultation Period: March 28, 2024, to April 26, 2024
CADTH is updating the procedures for provisional funding ...
Qualified rare disease registry owners can submit funding proposals to enhance the infrastructure, data quality, and utility of rare disease ...
Submission deadline: Friday, May 10, 2024
Nominations are now being accepted for 4 prestigious awards for outstanding achievement in the field of ...